These findings, and especially the result for those in the subgroup with obesity, suggest that perhaps with the right compound and the right dosing, a GLP-1 agonist may work
doi: 10.3389/fendo.2023.1269266 Summary Keywords epigenetic modifications, gut microbiota, metabolic dysfunction, polycystic ovary syndrome, therapeutic targets and drugs Citation Chen Y, Sun X, Xia X, Chen K and Zeng F (2026) The pathogenesis, therapeutic targets and drugs of polycystic ovary syndrome
Discounts and rewards This retailer has many price incentives, including ongoing discounts on certain items of up to 50%, as well as discount coupons and a lucrative rewards program for returning clients
J Physiol 589.4 pp 963-973
Autoimmune diseases
N.OguntibejuO